<VariationArchive RecordType="classified" VariationID="205685" VariationName="NM_001134407.3(GRIN2A):c.627del (p.Phe210fs)" VariationType="Deletion" Accession="VCV000205685" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-08-06" DateCreated="2015-08-07" MostRecentSubmission="2021-11-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="203373" VariationID="205685">
      <GeneList>
        <Gene Symbol="GRIN2A" FullName="glutamate ionotropic receptor NMDA type subunit 2A" GeneID="2903" HGNC_ID="HGNC:4585" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="9753404" stop="10182908" display_start="9753404" display_stop="10182908" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="9847264" stop="10276610" display_start="9847264" display_stop="10276610" Strand="-" />
          </Location>
          <OMIM>138253</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001134407.3(GRIN2A):c.627del (p.Phe210fs)</Name>
      <CanonicalSPDI>NC_000016.10:9938338:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="9938339" stop="9938339" display_start="9938339" display_stop="9938339" variantLength="1" positionVCF="9938338" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="10032196" stop="10032196" display_start="10032196" display_stop="10032196" variantLength="1" positionVCF="10032195" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>F210fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.9938340del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.9938340del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.10032197del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.10032197del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011812.2" sequenceAccession="NG_011812" sequenceVersion="2" change="g.249416del">
            <Expression>NG_011812.2:g.249416del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000833.5" sequenceAccession="NM_000833" sequenceVersion="5" change="c.627del">
            <Expression>NM_000833.5:c.627del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000824.1" sequenceAccession="NP_000824" sequenceVersion="1" change="p.Phe210fs">
            <Expression>NP_000824.1:p.Phe210fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001134407.3" sequenceAccession="NM_001134407" sequenceVersion="3" change="c.627del" MANESelect="true">
            <Expression>NM_001134407.3:c.627del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001127879.1" sequenceAccession="NP_001127879" sequenceVersion="1" change="p.Phe210fs">
            <Expression>NP_001127879.1:p.Phe210fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001134408.2" sequenceAccession="NM_001134408" sequenceVersion="2" change="c.627del">
            <Expression>NM_001134408.2:c.627del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001127880.1" sequenceAccession="NP_001127880" sequenceVersion="1" change="p.Phe210fs">
            <Expression>NP_001127880.1:p.Phe210fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001134407.3" sequenceAccession="NM_001134407" sequenceVersion="3" change="c.627delC" MANESelect="true">
            <Expression>NM_001134407.3:c.627delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA315002" DB="ClinGen" />
        <XRef Type="rs" ID="796052560" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001134407.3(GRIN2A):c.627del (p.Phe210fs) AND not provided" Accession="RCV000187672" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-10-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001134407.3(GRIN2A):c.627del (p.Phe210fs) AND Landau-Kleffner syndrome" Accession="RCV001781552" Version="1">
        <ClassifiedConditionList TraitSetID="12189">
          <ClassifiedCondition DB="MedGen" ID="C0282512">Landau-Kleffner syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-01-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-08-07" MostRecentSubmission="2021-11-29">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30544257</ID>
        </Citation>
        <DescriptionHistory Dated="2021-11-27">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12189" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5374" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">APHASIA, ACQUIRED, WITH EPILEPSY</ElementValue>
                <XRef Type="MIM" ID="245570" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy with neurodevelopmental defects</ElementValue>
                <XRef ID="Epilepsy+with+neurodevelopmental+defects/8322" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acquired aphasia with convulsive disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acquired epileptiform aphasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Landau-Kleffner syndrome</ElementValue>
                <XRef ID="Landau-Kleffner+syndrome/4080" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009509" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT</ElementValue>
                <XRef Type="MIM" ID="245570" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FESD</ElementValue>
                <XRef Type="MIM" ID="245570" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ADRESD</ElementValue>
                <XRef ID="245570" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RESDAD</ElementValue>
                <XRef ID="245570" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LKS</ElementValue>
                <XRef ID="245570" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">GRIN2A-Related Encephalopathy with Epilepsy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GRIN2A-Related Speech Disorders and Epilepsy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2A-related speech disorders and epilepsy are characterized by speech disorders in all affected individuals and a range of epilepsy syndromes present in about 90%. Severe speech disorders observed can include dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression; more mildly affected individuals may display subtly impaired intelligibility of conversational speech. Epilepsy features include seizure onset usually between ages three and six years, focal epilepsy with language and/or global developmental regression, and electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges. Seizure types include seizures associated with aura of perioral paresthesia, focal or focal motor seizures (often evolving to generalized tonic-clonic), and atypical absence seizures. Epilepsy syndromes can include: Landau-Kleffner syndrome (LKS), epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), childhood epilepsy with centrotemporal spikes (CECTS), atypical childhood epilepsy with centrotemporal spikes (ACECTS), autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD), and infantile-onset epileptic encephalopathy.</Attribute>
                <XRef ID="NBK385627" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6855" />
                <XRef ID="6855" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GRIN2A-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27683935</ID>
                <ID Source="BookShelf">NBK385627</ID>
              </Citation>
              <XRef ID="1945" DB="Orphanet" />
              <XRef ID="725" DB="Orphanet" />
              <XRef ID="98818" DB="Orphanet" />
              <XRef ID="C0282512" DB="MedGen" />
              <XRef ID="MONDO:0009509" DB="MONDO" />
              <XRef Type="MIM" ID="245570" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="445989" SubmissionDate="2015-07-30" DateLastUpdated="2015-08-07" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="24770" />
        <ClinVarAccession Accession="SCV000241269" DateUpdated="2015-08-07" DateCreated="2015-08-07" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-10-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>p.F210LfsX10: c.627delC in the GRIN2A gene (NM_000833.3). The c.627delC mutation in the GRIN2A gene has not been reported previously, to our knowledge. This mutation causes a frameshift starting with codon Phenylalanine 210, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 10 of the new reading frame, denoted p.Phe210LeufsX10 (F210LfsX10). This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Although this mutation has not been previously reported to our knowledge, loss of function due to a nonsense mutation in GRIN2A has been reported previously in association with a GRIN2A-related phenotype (Endele et al., 2010). We interpret c.627delC as a disease-causing mutation. This variant has been observed de novo without verified parentage. The variant is found in GRIN2A panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRIN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.F210LfsX10</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000833.3:c.627delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3969682" SubmissionDate="2021-11-23" DateLastUpdated="2021-11-29" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="CVb_803|OMIM:245570" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002026169" DateUpdated="2021-11-29" DateCreated="2021-11-29" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30544257</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRIN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001134407.3:c.627delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="245570" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10703643</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3969682" TraitType="Disease" MappingType="XRef" MappingValue="245570" MappingRef="OMIM">
        <MedGen CUI="C0282512" Name="Landau-Kleffner syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="445989" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

